Zdrowie i gospodarka · 05/03/2014

FDA Releases Guidance on Documenting Postapproval Manufacturing Changes in Annual Reports

The Food and Drug Administration (FDA) has published a guidance document outlining the types of postapproval manufacturing changes that should be documented in annual reports for new and abbreviated drug applications, with the aim of ensuring product quality.